Combining GLP-1 and glucagon for the treatment of obesity and diabetes

被引：0
|
作者：
Idris, Iskandar [1 ]
机构：
[1] Univ Nottingham, Nottingham NG7 2RD, England
来源：
DIABETES OBESITY & METABOLISM | 2013年 / 15卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：481 / 482
页数：2
相关论文
共 50 条
  • [21] Discovery of MK-1462: GLP-1 and Glucagon Receptor Dual Agonist for the Treatment of and Diabetes
    Palani, Anandan
    Nawrocki, Andrea R.
    Orvieto, Federica
    Bianchi, Elisabetta
    Mandic, Emanuela
    Pessi, Antonello
    Huang, Chunhui
    Deng, Qiaolin
    Toussaint, Nathalie
    Walsh, Erika
    Reddy, Vijay
    Ashley, Eric
    He, Huaibing
    Mumick, Sheena
    Hawes, Brian
    Marsh, Donald
    Erion, Mark
    Nargund, Ravi
    Carrington, Paul E.
    ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (08): : 1248 - 1254
  • [22] Activators of the GLP-1 receptor in diabetes treatment
    Holst, JJ
    JOURNAL OF BIOTECHNOLOGY, 2005, 118 : S62 - S63
  • [23] Oral GLP-1 Modulators for the Treatment of Diabetes
    Edmonds, David J.
    Price, David A.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 48, 2013, 48 : 119 - 130
  • [24] A glucagon-like peptide-1 (GLP-1) receptor agonist in the treatment for hypothalamic obesity complicated by type 2 diabetes mellitus
    Thondam, S. K.
    Cuthbertson, D. J.
    Aditya, B. S.
    MacFarlane, I. A.
    Wilding, J. P.
    Daousi, C.
    CLINICAL ENDOCRINOLOGY, 2012, 77 (04) : 635 - 637
  • [25] Liraglutide. GLP-1 receptor agonist, Treatment of type 2 diabetes, Treatment of obesity
    Gallwitz, B.
    DRUGS OF THE FUTURE, 2008, 33 (01) : 13 - 20
  • [26] GLP-1 Restores Altered Insulin and Glucagon Secretion in Posttransplantation Diabetes
    Halden, Thea A. S.
    Egeland, Erlend J.
    Asberg, Anders
    Hartmann, Anders
    Midtvedt, Karsten
    Khiabani, Hassan Z.
    Holst, Jens J.
    Knop, Filip K.
    Hornum, Mads
    Feldt-Rasmussen, Bo
    Jenssen, Trond
    DIABETES CARE, 2016, 39 (04) : 617 - 624
  • [27] Glucagon-like peptide-1 (GLP-1) receptor agonists, obesity and psoriasis: diabetes meets dermatology
    Drucker, D. J.
    Rosen, C. F.
    DIABETOLOGIA, 2011, 54 (11) : 2741 - 2744
  • [28] Glucagon-like peptide-1 (GLP-1) receptor agonists, obesity and psoriasis: diabetes meets dermatology
    D. J. Drucker
    C. F. Rosen
    Diabetologia, 2011, 54 : 2741 - 2744
  • [29] Achievement of BMI <25 Through Obesity Treatment Combining GLP-1 Medication and ILI
    Medeiros, Kaelen
    Boyd, Kim
    Ryan, Donna
    OBESITY, 2024, 32 : 299 - 299
  • [30] Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes
    Manell, Hannes
    Staaf, Johan
    Manukyan, Levon
    Kristinsson, Hjalti
    Cen, Jing
    Stenlid, Rasmus
    Ciba, Iris
    Forslund, Anders
    Bergsten, Peter
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (03): : 1181 - 1189
12345